Picture of Valbiotis SA logo

ALVAL — Valbiotis SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Valbiotis Presents Positive Results From A Study On TOTUM-63

Sept 16 (Reuters) - VALBIOTIS SA  ALVAL.PA :
    * VALBIOTIS PRESENTS POSITIVE RESULTS FROM A STUDY ON
TOTUM-63,
ACTIVE SUBSTANCE OF VALEDIA®, CONDUCTED BY THE CARMEN LABORATORY
IN LYON, AT THE ANNUAL MEETING OF THE EUROPEAN ASSOCIATION FOR
THE STUDY OF DIABETES (EASD)
    * DATA DEMONSTRATES CAPACITY OF TOTUM-63 TO SIGNIFICANTLY
CORRECT
SECRETION OF THREE HORMONES
    * PRECLINICAL STUDY CONFIRMS MAJOR EFFECTS OF ACTIVE
SUBSTANCE
TOTUM-63 ON WEIGHT AND GLUCOSE METABOLISM

Source text for Eikon:  ID:nBw1mGfnka 
Further company coverage:  ALVAL.PA 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))

Recent news on Valbiotis SA

See all news